United States Biotechnology & Medical Research

Neuphoria Therapeutics Inc (NEUP)

Neuphoria Therapeutics Inc recorded a significant acquisition on October 21, 2025, when Lynx1 Capital Management LP purchased 639,110 shares valued at approximately 3.28 million dollars. This transaction represents the most recent activity observed for the firm. No further insider trading has been reported within the last three months.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: NEUP Exchange: NMS

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Neuphoria Therapeutics Inc

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

4.1

Lynx1 Capital Management LP Large shareholder

Transaction date 21 Oct 2025

Purchase

Price

56.82

Quantity 38,252 +20.6%

Value US$4,553,048

Comments Filing

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-10-23	2025-10-21	B Purchase	4.1 Lynx1 Capital Management LP Large shareholder	38,252 +20.6% 56.82 US$4,553,048	38,252 +20.6%	56.82	US$4,553,048